Neuralstem to Participate at Cell and Gene Therapy World

GERMANTOWN, Md., Jan. 22 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced Karl Johe, Ph.D, Chief Scientific Officer of Neuralstem, will discuss NSI-566, the Company’s stem cell therapy program, at the Cell and Gene Therapy World at the Hyatt Regency in Miami, FL.  The presentation [...]